Is the Treponema pallidum particle agglutination (TPPA) test the same as the Treponema pallidum hemagglutination (TPHA) test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

TPPA and TPHA: Essentially the Same Test with Different Methodologies

TPPA (Treponema pallidum particle agglutination) and TPHA (Treponema pallidum hemagglutination) are functionally equivalent treponemal-specific tests for syphilis diagnosis that use the same principle but differ in their particle carrier—TPPA uses gelatin particles while TPHA uses red blood cells. Both tests detect antibodies to T. pallidum and serve the same clinical purpose as confirmatory treponemal tests.

Key Similarities

Both tests:

  • Are treponemal-specific antibody tests used to confirm syphilis diagnosis 1, 2
  • Remain reactive for life in most patients regardless of treatment (15-25% may revert to non-reactive after 2-3 years if treated during primary stage) 1
  • Should not be used to monitor treatment response as titers correlate poorly with disease activity 1
  • Have equivalent clinical performance with excellent agreement (96.7-100%) when compared head-to-head 3

Technical Differences

The primary distinction is the carrier particle:

  • TPPA: Uses gelatin particles coated with T. pallidum antigens
  • TPHA: Uses red blood cells (hemagglutination) coated with T. pallidum antigens 4

Recent evidence demonstrates that TPHAs are acceptable alternatives to TPPA with positive percent agreement of 99.2-100% and negative percent agreement of 97.8-98.9% 4. Clinical sensitivity for active untreated syphilis was equivalent at 97.2% for both methodologies 4.

Clinical Implications

Use either test interchangeably for:

  • Confirmatory testing after positive nontreponemal tests (RPR/VDRL) 1, 2
  • Reverse sequence algorithm adjudication 5
  • Neurosyphilis diagnosis when performed on CSF (CSF-TPPA or CSF-TPHA with titer ≥1:640 shows high specificity of 93-94%) 6, 7

Important Caveat

TPPA availability has been withdrawn in some regions (Australia, Europe), making TPHA the necessary alternative 4, 8. The 2025 evaluation confirms TPHAs maintain excellent performance characteristics and provide confidence as acceptable substitutes in settings without TPPA access 4.

Bottom line: These tests are clinically interchangeable—choose whichever is available in your laboratory, as both provide equivalent diagnostic accuracy for syphilis confirmation.

References

Research

Performance of Treponemal Tests for the Diagnosis of Syphilis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019

Related Questions

What is the confirmatory test for syphilis in a pregnant female with a 1:1 Rapid Plasma Reagin (RPR) titer?
What are the advantages and disadvantages of treponemal tests (e.g., fluorescent treponemal antibody absorption [FTA‑ABS], Treponema pallidum particle agglutination [TP‑PA], chemiluminescence immunoassay [CIA]) compared with non‑treponemal tests (e.g., venereal disease research laboratory [VDRL], rapid plasma reagin [RPR], toluidine red unheated serum test [TRUST]) for syphilis?
What does a positive fluorescent treponemal antibody absorption (FTA‑ABS) test indicate and what is the recommended treatment for syphilis?
How reliable is a treponemal enzyme immunoassay (EIA) performed 130 days after exposure for ruling out syphilis, given a single 200 mg dose of doxycycline taken on the day of exposure and no further sexual contacts?
Can I order a treponema pallidum hemagglutination assay (TPHA) for a patient with a new penile ulcer?
What is the recommended treatment for a patient with anti‑Ro52 (SSA‑52) positive interstitial lung disease?
Can left‑side high‑frequency transcranial magnetic stimulation (TMS) cause decreased libido?
What is the appropriate evaluation work‑up for suspected allergic bronchopulmonary aspergillosis (ABPA) in a patient with asthma or cystic fibrosis?
How can a patient taper a 40 mg pantoprazole dose when 20 mg tablets are unavailable?
How is the Ponderal index interpreted in neonates with intrauterine growth restriction (IUGR)?
What gastrointestinal effects are associated with using a 5% nicotine vaping product and how should they be managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.